These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 4359964)

  • 1. Defective superoxide production by granulocytes from patients with chronic granulomatous disease.
    Curnutte JT; Whitten DM; Babior BM
    N Engl J Med; 1974 Mar; 290(11):593-7. PubMed ID: 4359964
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Superoxide radical and the bactericidal action of phagocytes.
    Fridovich I
    N Engl J Med; 1974 Mar; 290(11):624-5. PubMed ID: 4591067
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes.
    Root RK; Rosenthal AS; Balestra DJ
    J Clin Invest; 1972 Mar; 51(3):649-65. PubMed ID: 4400956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes.
    Curnutte JT; Babior BM
    J Clin Invest; 1974 Jun; 53(6):1662-72. PubMed ID: 4364409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes.
    Weening RS; Wever R; Roos D
    J Lab Clin Med; 1975 Feb; 85(2):245-52. PubMed ID: 163283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Leukocyte superoxide in chronic granulomatous disease.
    Saccoccia P
    N Engl J Med; 1974 Jun; 290(23):1328. PubMed ID: 4827638
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic granulomatous disease. Clinical symptoms and biochemical background].
    Weening RS; Kollee LA; van Gool JD; Roos D
    Ned Tijdschr Geneeskd; 1976 Aug; 120(35):1480-7. PubMed ID: 184401
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.
    Johnston RB; Keele BB; Misra HP; Lehmeyer JE; Webb LS; Baehner RL; RaJagopalan KV
    J Clin Invest; 1975 Jun; 55(6):1357-72. PubMed ID: 166094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.
    Babior BM; Kipnes RS; Curnutte JT
    J Clin Invest; 1973 Mar; 52(3):741-4. PubMed ID: 4346473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the pathogenesis of chronic granulomatous disease. 2. Impaired activation of glucose-6-phosphate dehydrogenase in leukocytes of a patient with chronic granulomatous disease during phagocytosis.
    Usui T; Shimizu B; Amano D; Ishibashi S; Murakami K
    Hiroshima J Med Sci; 1971 Dec; 20(4):245-53. PubMed ID: 5149957
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyridine nucleotide-dependent superoxide production by a cell-free system from human granulocytes.
    Babior BM; Curnutte JT; Kipnes BS
    J Clin Invest; 1975 Oct; 56(4):1035-42. PubMed ID: 239968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal kinetics of degranulation in chronic granulomatous disease.
    Gold SB; Hanes DM; Stites DP; Fudenberg HH
    N Engl J Med; 1974 Aug; 291(7):332-7. PubMed ID: 4850362
    [No Abstract]   [Full Text] [Related]  

  • 13. Disorders of phagocyte function: biochemical aspects.
    Quie PG
    Prog Clin Biol Res; 1977; 13():157-69. PubMed ID: 45476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic granulomatous disease--pieces of a cellular and molecular puzzle.
    Karnovsky ML
    Fed Proc; 1973 Apr; 32(4):1527-33. PubMed ID: 4144970
    [No Abstract]   [Full Text] [Related]  

  • 15. Defect in pyridine nucleotide dependent superoxide production by a particulate fraction from the granulocytes of patients with chronic granulomatous disease.
    Curnutte JT; Kipnes RS; Babior BM
    N Engl J Med; 1975 Sep; 293(13):628-32. PubMed ID: 239342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and defective phagocytosis. Theory, clinical aspects and laboratory diagnosis.
    Hitzig WH
    Triangle; 1973; 12(2):57-67. PubMed ID: 4583529
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered levels of glucose-6-phosphate dehydrogenase stabilizing factors in X-linked chronic granulomatous disease.
    Erickson RP; Stites DP; Fudenberg HH; Epstein CJ
    J Lab Clin Med; 1972 Nov; 80(5):644-53. PubMed ID: 4404227
    [No Abstract]   [Full Text] [Related]  

  • 18. Phagocytosis in chronic granulomatous disease and the Chediak-Higashi syndrome.
    Stossel TP; Root RK; Vaughan M
    N Engl J Med; 1972 Jan; 286(3):120-3. PubMed ID: 5007151
    [No Abstract]   [Full Text] [Related]  

  • 19. The mechanism of bacterial killing by normal and chronic granulomatous disease leukocytes.
    Johnston RB
    Birth Defects Orig Artic Ser; 1975; 11(1):71-2. PubMed ID: 167886
    [No Abstract]   [Full Text] [Related]  

  • 20. [Description of a case of infantile chronic granulomatous disease on a granulocytopathic base].
    Meroni R; D'Amico E
    Minerva Pediatr; 1977 May; 29(17):1135-40. PubMed ID: 875995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.